MedPath

Investigation of the Effects of Online Education Application on Gynecological Cancer Patients Receiving Chemotherapy

Not Applicable
Completed
Conditions
Gynecological Cancer
Interventions
Other: Chemotherapy symptom Management Online Education
Registration Number
NCT06574256
Lead Sponsor
Celal Bayar University
Brief Summary

The aim of the study was to examine the effect of online nursing education given to women diagnosed with gynecological cancer and receiving chemotherapy. It was conducted as a randomized controlled experimental study. The study examined the effect of online nursing education given to patients in the intervention group diagnosed with gynecological cancer and receiving chemotherapy on symptoms, quality of life and patient satisfaction. The control group received routine nursing care.

Detailed Description

This study examined the effect of online nursing education given to women diagnosed with gynecological cancer and receiving chemotherapy. This randomized controlled experimental study was conducted in a public hospital in Balıkesir province between December 1, 2021 and June 1, 2024. The study sample consisted of 90 women (intervention=45, control=45). Online nursing education was given to women in the intervention group receiving chemotherapy. Patients in the control group received routine nursing care. The study used the women's descriptive characteristics questionnaire, disease and treatment questionnaire, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Nightingale Symptom Assessment Scale, nurse follow-up form and patient satisfaction questionnaire. Data were collected during three chemotherapy cycles in four phases.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • Patients who are diagnosed with gynecological cancer and who have started chemotherapy treatment for the first time in the hospital,

having gynecological cancer

receiving chemotherapy

Speak Turkish, have no communication problems,

Accept voluntarily to participate in the study,

Patients who are 18 years of age or older

Read More
Exclusion Criteria
  • Illiterate Patients who do not have a smart phone or computer Patients who receive radiotherapy together with chemotherapy Patients who do not know they have been diagnosed with cancer
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
intervention groupChemotherapy symptom Management Online EducationPatients in the intervention group will receive online nursing education and their quality of life and symptom complaints will be monitored by the nurse who provides education during three cycles of chemotherapy. At the end of the third cycle, patients' satisfaction with this education will be determined.
Primary Outcome Measures
NameTimeMethod
EORT QLQ-C30three monhts

EORT QLQ-C30: It consists of three main dimensions and 30 questions, namely general well-being, functional difficulties and symptom control.

Nightingale symptom assessment scalethree monhts

Nightingale symptom assessment scale: This scale, consisting of 38 items, has three sub-dimensions, namely physical, social and psychological well-being.

Secondary Outcome Measures
NameTimeMethod
Nightingale Symptom Assessment Scalethree months

Nightingale symptom assessment scale: This scale, consisting of 38 items, has three sub-dimensions: physical, social and psychological well-being. This is a Likert-type scale. The total sub-dimension score is calculated by adding the item scores in each sub-dimension and dividing by the number of items. 0-4 points are taken in each subscale of the scale. A high score indicates that the level of being affected by problems caused by the disease/treatment is high.

European Organization for Research and Treatment of Cancer Quality of Life Questionnaire,three monhts

EORT QLQ-C30: It consists of three main dimensions and 30 questions: general well-being, functional difficulties and symptom control. İThe first 28 questions are Likert-type. The other two questions are evaluated as 1: very bad and 7: excellent. Each subscale of the scale is scored between 0-100. High scores from the sub-dimension and general quality of life indicate that the quality of life is high, and high scores from the symptom scale indicate that the symptoms experienced are at a high level.

patient satisfactionone months

score average is taken.

Trial Locations

Locations (1)

CelalBayarU

🇹🇷

Manisa, Turkey

© Copyright 2025. All Rights Reserved by MedPath